Priming of protective T cell responses against virus-induced tumors in mice with human immune system components Journal Article


Authors: Strowig, T.; Gurer, C.; Ploss, A.; Liu, Y. F.; Arrey, F.; Sashihara, J.; Koo, G.; Rice, C. M.; Young, J. W.; Chadburn, A.; Cohen, J. I.; Münz, C.
Article Title: Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Abstract: Many pathogens that cause human disease infect only humans. To identify the mechanisms of immune protection against these pathogens and also to evaluate promising vaccine candidates, a small animal model would be desirable. We demonstrate that primary T cell responses in mice with reconstituted human immune system components control infection with the oncogenic and persistent Epstein-Barr virus (EBV). These cytotoxic and interferon-γ-producing T cell responses were human leukocyte antigen (HLA) restricted and specific for EBV-derived peptides. In HLA-A2 transgenic animals and similar to human EBV carriers, T cell responses against lytic EBV antigens dominated over recognition of latent EBV antigens. T cell depletion resulted in elevated viral loads and emergence of EBV-associated lymphoproliferative disease. Both loss of CD4 <sup>+</sup> and CD8<sup>+</sup> T cells abolished immune control. Therefore, this mouse model recapitulates features of symptomatic primary EBV infection and generates T cell-mediated immune control that resists oncogenic transformation. © 2009 Strowig et al.
Keywords: controlled study; nonhuman; neoplasms; cd8+ t lymphocyte; t lymphocyte; t-lymphocytes; mouse; animals; mice; mice, knockout; animal tissue; immune system; spleen; animal experiment; animal model; mice, scid; mice, transgenic; kidney; cellular immunity; gamma interferon; cd4+ t lymphocyte; lymphoproliferative disease; virus load; disease models, animal; t cell depletion; mice, inbred nod; cell protection; herpes; epstein barr virus; herpesvirus 4, human; hla system; hla a2 antigen; virus carrier; virus isolation; epstein-barr virus infections; hla-a2 antigen
Journal Title: Journal of Experimental Medicine
Volume: 206
Issue: 6
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 2009-06-08
Start Page: 1423
End Page: 1434
Language: English
DOI: 10.1084/jem.20081720
PUBMED: 19487422
PROVIDER: scopus
PMCID: PMC2715061
DOI/URL:
Notes: --- - "Cited By (since 1996): 13" - "Export Date: 30 November 2010" - "CODEN: JEMEA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James W Young
    319 Young
  2. Gloria C Koo
    6 Koo